Latest News
IL-2 Immunotherapy Fails to Benefit HIV-Infected Individuals Already Taking Antiretrovirals
Feb. 10, 2009
Q & A: The ESPRIT and SILCAAT HIV Treatment Clinical Studies
Feb. 10, 2009
NIAID Media Availability: New Mathematical Model of Pre-Exposure Prophylaxis (PrEP) Against HIV Forecasts Substantial Benefits, Potential Cost-Effectiveness
Feb. 9, 2009
Anti-HIV Gel Shows Promise in Large-scale Study in Women
Feb. 9, 2009
Highlights
Food Allergy Clinical Guidelines
Register for workshop on vaccine adjuvants and adjuvanted vaccines
Summit on HIV Vaccine Research and Development Meeting